S&P 500 7,350.29 â–ŧ 7.93 (-0.11%) DOW 51,869.66 ▲ 20.76 (+0.04%) NASDAQ 25,330.58 â–ŧ 146.05 (-0.57%) US Markets Closed â€ĸ 07:15 PM ET

ITOC

iTonic Holdings Ltd.

Price Chart
Latest Quote

$0.31

-0.02 (-4.73%)
Current Price
Previous Close $0.33
Open $0.32
Day High $0.33
Day Low $0.30
Volume 171,959
Fetched: 2026-06-25T23:15:38
Stock Information
Shares Outstanding 9.38M
Total Debt $143K
Cash Equivalents $2.93M
Revenue $523K
Net Income $-5.10M
Sector Healthcare
Industry Medical Devices
Market Cap $7.66M
EPS (TTM) $-0.32
Exchange NCM
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$4.77M
Sales$523K
Income$-5.10M
Book/sh$0.36
Cash/sh$0.31
Employees7
Financial Ratios
Quick Ratio6.95
Current Ratio8.83
Debt/Eq1.76
Returns & Margins
ROA-40.98%
ROE-71.25%
Gross Margin62.59%
Operating Margin-681.94%
Ownership
Insider Ownership1.82%
Institutional Ownership0.10%
Insider & Institutional transactions data not available
Valuation Ratios
P/S14.65
P/B0.86
Analyst Data
Recommendationnone
Technical Indicators
SMA20$0.34
SMA50$0.33
SMA200$0.48
RSI50.85
ATR0.1241
Shares Float15.64M
Short Float2.12%
Short Ratio2.56
Rel Volume0.07
Performance History
Week-8.82%
Month+3.33%
Quarter-25.12%
6 Months-29.86%
YTD-28.57%
Year-98.35%
10 Years-91.80%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-25 $0.31 171,959
2026-06-24 $0.32 536,300
2026-06-23 $0.32 60,100
2026-06-22 $0.32 54,600
2026-06-18 $0.31 177,000
2026-06-17 $0.34 7,232,800
2026-06-16 $0.35 97,200
2026-06-15 $0.33 344,900
2026-06-12 $0.34 185,900
2026-06-11 $0.41 485,100
2026-06-10 $0.43 1,657,900
2026-06-09 $0.40 3,534,700
2026-06-08 $0.51 34,332,900
2026-06-05 $0.28 39,500
2026-06-04 $0.30 28,200
2026-06-03 $0.28 52,500
2026-06-02 $0.28 25,400
2026-06-01 $0.30 22,700
2026-05-29 $0.30 37,700
2026-05-28 $0.30 55,200
2026-05-27 $0.30 20,800
2026-05-26 $0.30 48,900
About iTonic Holdings Ltd.

iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients. The company was formerly known as Pheton Holdings Ltd and changed its name to iTonic Holdings Ltd. in January 2026. iTonic Holdings Ltd. was founded in 1998 and is headquartered in Beijing, China. iTonic Holdings Ltd. operates as a subsidiary of ZJW (BVI) LTD.

📰 Latest News
No news articles available at the moment. Check back later for updates on ITOC.
Period:
Loading...
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Reconciled Cost Of Revenue $195,680 $67,041 $157,763 $121,627
Cost Of Revenue $195,680 $67,041 $157,763 $121,627
Total Revenue $523,031 $448,196 $628,591 $679,777
Operating Revenue $523,031 $448,196 $628,591 $679,777
Expenses
Total Expenses $5,687,724 $1,110,153 $887,103 $605,248
Other Income Expense $66,309 $23,198 $-1,996 $-3,502
Other Non Operating Income Expenses $66,309 $23,198 $-1,996 $-3,502
Operating Expense $5,492,044 $1,043,112 $729,340 $483,621
Other Operating Expenses $-22,270 $-108,309 $-48,168 $-47,008
Selling And Marketing Expense $181,853 $307,534 $268,135 $294,856
General And Administrative Expense $4,873,326 $750,563 $424,899 $162,056
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-5,097,901 $-660,588 $-241,217 $83,980
Normalized Income $-5,097,901 $-660,588 $-241,217 $83,980
Net Income From Continuing And Discontinued Operation $-5,097,901 $-660,588 $-241,217 $83,980
Total Operating Income As Reported $-5,186,963 $-770,266 $-306,680 $27,521
Net Income Common Stockholders $-5,097,901 $-660,588 $-241,217 $83,980
Net Income $-5,097,901 $-660,588 $-241,217 $83,980
Net Income Including Noncontrolling Interests $-5,098,384 $-660,588 $-241,217 $83,980
Net Income Continuous Operations $-5,098,384 $-660,588 $-241,217 $83,980
Pretax Income $-5,098,384 $-638,759 $-260,508 $71,027
Operating Income $-5,164,693 $-661,957 $-258,512 $74,529
Gross Profit $327,351 $381,155 $470,828 $558,150
Per Share
Diluted EPS - $-0.05 $-0.02 $0.01
Basic EPS - $-0.05 $-0.02 $0.01
Other
Tax Effect Of Unusual Items $0 $0 $0 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-5,151,379 $-589,526 $-195,378 $128,613
Reconciled Depreciation $13,314 $72,431 $63,134 $54,084
EBITDA (Bullshit earnings) $-5,151,379 $-589,526 $-195,378 $128,613
EBIT $-5,164,693 $-661,957 $-258,512 $74,529
Diluted NI Availto Com Stockholders $-5,097,901 $-660,588 $-241,217 $83,980
Minority Interests $483 $0 $0 -
Tax Provision $0 $21,829 $-19,291 $-12,953
Research And Development $459,135 $93,324 $84,474 $73,717
Selling General And Administration $5,055,179 $1,058,097 $693,034 $456,912
Other Gand A $4,873,326 $750,563 $424,899 $162,056
Diluted Average Shares - $12,721,233 $12,000,000 $12,000,000
Basic Average Shares - $12,721,233 $12,000,000 $12,000,000
Fetched: 2026-06-19
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $1,752,927 $6,184,703 $306,272 $556,322
Total Assets $9,096,296 $6,723,254 $1,616,636 $1,401,734
Total Non Current Assets $5,007,858 $45,594 $1,084,168 $682,929
Non Current Prepaid Assets $600,000 $0 $14,468 $16,140
Goodwill And Other Intangible Assets $4,370,040 $0 - -
Other Intangible Assets $2,414,357 - - -
Current Assets $4,088,438 $6,677,660 $532,468 $718,805
Other Current Assets $122,898 $490 $6,580 $3,605
Prepaid Assets $698,575 $91,863 $11,715 $15,037
Inventory $52,479 $117,422 $52,263 $152,788
Receivables $288,456 $308,062 $234,460 $475,087
Taxes Receivable $0 $26,477 $28,131 $27,017
Accounts Receivable $288,456 $281,585 $206,329 $448,070
Allowance For Doubtful Accounts Receivable $-166,310 $-106,780 $-71,341 $-50,850
Gross Accounts Receivable $454,766 $388,365 $277,670 $498,920
Cash Cash Equivalents And Short Term Investments $2,926,030 $6,159,823 $217,885 $72,288
Cash And Cash Equivalents $1,490,129 $6,159,823 $217,885 $72,288
Cash Financial $1,490,129 $6,159,823 $217,885 $72,288
Non Current Deferred Assets - $0 $854,685 $448,861
Non Current Deferred Taxes Assets - $0 $22,124 $2,940
Restricted Cash - $0 $9,565 $0
Debt
Total Debt $142,998 $247,969 $155,818 $218,326
Current Debt And Capital Lease Obligation $142,998 $247,969 $50,825 $53,315
Current Debt $142,998 $247,969 - -
Long Term Debt And Capital Lease Obligation - $0 $104,993 $165,011
Liabilities
Total Liabilities Net Minority Interest $969,832 $538,551 $1,310,364 $845,412
Total Non Current Liabilities Net Minority Interest $507,015 $0 $104,993 $165,011
Non Current Deferred Liabilities $507,015 $0 - -
Non Current Deferred Taxes Liabilities $507,015 $0 - -
Current Liabilities $462,817 $538,551 $1,205,371 $680,401
Current Deferred Liabilities $186,024 $145,899 $58,246 $151,322
Payables And Accrued Expenses $133,795 $144,683 $1,096,300 $431,334
Payables $132,437 $120,133 $1,096,300 $431,334
Other Payable $51,012 $77,039 $58,977 $32,996
Total Tax Payable $14,543 $32,682 $27,296 $1,826
Accounts Payable $66,882 $10,412 $18,000 $11,171
Other Current Liabilities - - $21,159 $44,430
Income Tax Payable - - - $0
Equity
Common Stock Equity $6,122,967 $6,184,703 $306,272 $556,322
Total Equity Gross Minority Interest $8,126,464 $6,184,703 $306,272 $556,322
Stockholders Equity $6,122,967 $6,184,703 $306,272 $556,322
Gains Losses Not Affecting Retained Earnings $41,517 $41,505 $46,621 $56,582
Other Equity Adjustments $41,517 $41,505 $46,621 $56,582
Retained Earnings $-5,620,752 $-522,851 $137,737 $378,954
Other
Ordinary Shares Number $17,050,000 $14,250,000 $14,250,000 $14,250,000
Share Issued $17,050,000 $14,250,000 $14,250,000 $14,250,000
Tangible Book Value $1,752,927 $6,184,703 $306,272 $556,322
Invested Capital $6,265,965 $6,432,672 $306,272 $556,322
Working Capital $3,625,621 $6,139,109 $-672,903 $38,404
Total Capitalization $6,122,967 $6,184,703 $306,272 $556,322
Minority Interest $2,003,497 $0 - -
Additional Paid In Capital $11,700,497 $6,664,624 $120,714 $119,586
Capital Stock $1,705 $1,425 $1,200 $1,200
Common Stock $1,705 $1,425 $1,200 $1,200
Current Deferred Revenue $186,024 $145,899 $58,246 $151,322
Line Of Credit $142,998 $247,969 $0 -
Current Accrued Expenses $1,358 $24,550 $0 $44,430
Goodwill $1,955,683 $0 - -
Net PPE $37,818 $45,594 $215,015 $217,928
Gross PPE $37,818 $45,594 $215,015 $217,928
Other Properties $37,818 $45,594 $215,015 $217,928
Other Short Term Investments $1,435,901 $0 - -
Capital Lease Obligations - $0 $155,818 $218,326
Long Term Capital Lease Obligation - $0 $104,993 $165,011
Current Capital Lease Obligation - $0 $50,825 $53,315
Dueto Related Parties Current - $0 $992,027 $385,341
Duefrom Related Parties Current - - - $0
Fetched: 2026-06-19
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $-3,235,233 $-775,861 $-63,636 $-116,152
Operating Activities
Operating Cash Flow $-3,231,427 $-775,000 $-63,636 $-116,152
Cash Flow From Continuing Operating Activities $-3,231,427 $-775,000 $-63,636 $-116,152
Operating Gains Losses - $-16,091 - -
Investing Activities
Capital Expenditure $-3,806 $-861 - -
Investing Cash Flow $-1,352,149 $-861 $0 $0
Cash Flow From Continuing Investing Activities $-1,352,149 $-861 $0 $0
Financing Activities
Issuance Of Capital Stock $168,392 $7,795,642 $1,128 $0
Financing Cash Flow $-91,645 $6,712,263 $220,592 $78,135
Cash Flow From Continuing Financing Activities $-91,645 $6,712,263 $220,592 $78,135
Net Other Financing Charges $-139,130 $-1,334,918 $219,464 $476,579
Cash Dividends Paid $0 $0 $0 $-398,444
Net Common Stock Issuance $168,392 $7,795,642 $1,128 $0
Common Stock Issuance $168,392 $7,795,642 $1,128 $0
Common Stock Dividend Paid - $0 $0 $-398,444
Other
Repayment Of Debt $-251,826 $-6,949 $0 $0
Issuance Of Debt $139,826 $258,488 $0 $0
Interest Paid Supplemental Data $8,907 $9,166 $0 -
Income Tax Paid Supplemental Data $0 $0 $0 $0
End Cash Position $1,490,129 $6,159,823 $227,450 $72,288
Beginning Cash Position $6,159,823 $227,450 $72,288 $136,750
Effect Of Exchange Rate Changes $5,527 $-4,029 $-1,794 $-26,445
Changes In Cash $-4,675,221 $5,936,402 $156,956 $-38,017
Interest Paid Cff $-8,907 $0 $0 -
Net Issuance Payments Of Debt $-112,000 $251,539 $0 $0
Net Short Term Debt Issuance $-112,696 $251,539 $0 $0
Short Term Debt Payments $-251,826 $-6,949 $0 $0
Short Term Debt Issuance $139,130 $258,488 $0 $0
Net Long Term Debt Issuance $696 $0 $0 $456,027
Long Term Debt Issuance $696 $0 $0 $570,486
Net Investment Purchase And Sale $-1,400,000 $0 $0 -
Purchase Of Investment $-1,400,000 $0 $0 -
Net Business Purchase And Sale $51,657 - - -
Sale Of Business $51,657 - - -
Net PPE Purchase And Sale $-3,806 $-861 $0 $0
Purchase Of PPE $-3,806 $-861 $0 $0
Change In Working Capital $-1,154,130 $-230,508 $112,221 $-267,646
Change In Other Working Capital $11,081 $94,698 $-101,732 $137,335
Change In Other Current Liabilities $0 $-40,787 $-57,201 $-51,447
Change In Other Current Assets $-600,000 $0 $1,369 $0
Change In Payables And Accrued Expense $145,613 $-17,335 $26,912 $15,536
Change In Accrued Expense $89,618 $-10,136 $19,851 $37,986
Change In Payable $55,995 $-7,199 $7,061 $-22,450
Change In Account Payable $55,995 $-7,199 $7,061 $-11,587
Change In Prepaid Assets $-730,953 $-79,555 $-2,937 $-23,722
Change In Inventory $68,189 $-67,545 $33,499 $-63,942
Change In Receivables $-48,060 $-119,984 $212,311 $-281,406
Changes In Account Receivables $-48,060 $-119,984 $212,311 $-281,406
Other Non Cash Items $8,907 - - -
Stock Based Compensation $2,945,495 $0 $0 -
Provisionand Write Offof Assets $53,371 $37,927 $21,517 $15,520
Deferred Tax $0 $21,829 $-19,291 $-2,090
Deferred Income Tax $0 $21,829 $-19,291 $-2,090
Depreciation Amortization Depletion $13,314 $72,431 $63,134 $54,084
Depreciation And Amortization $13,314 $72,431 $63,134 $54,084
Depreciation $13,314 $72,431 $63,134 $54,084
Gain Loss On Sale Of PPE $0 $-16,091 $0 $0
Net Income From Continuing Operations $-5,098,384 $-660,588 $-241,217 $83,980
Change In Tax Payable - $0 $0 $-10,863
Change In Income Tax Payable - $0 $0 $-10,863
Long Term Debt Payments - - $-138,400 $-114,459
Fetched: 2026-06-19